Bromelain improved cognitive & mood behaviors, oxido-inflammatory indices and cholinergic transmission in scopolamine-induced neurotoxicity in male wistar rats.
Bromelain reduced scopolamine neurotoxicity.
##doi.readerDisplayName##:
https://doi.org/10.54548/njps.v39i2.8Апстракт
Alzheimer’s disease (AD) is associated with pathophysiological and psychological disturbances including cognitive decline, depression, anxiety and motor imbalance. Conventional drugs for managing AD do not address associated non-neurocognitive co-morbidities, hence the need to investigate alternative therapies especially from plants. The neuroprotective benefits of bromelain have been identified, but its impacts on scopolamine-induced neurotoxicity is yet to be elucidated. Twenty-Five male rats were separated randomly into 5 groups: Control (normal saline; 1ml/kg); Scopolamine (i.p; 1mg/kg); Bromelain (50mg/kg); Scopolamine + Bromelain; Scopolamine + Donepezil (reference drug, 1mg/kg). Neurobehavioral paradigms (novel object recognition, elevated plus maze, forced swimming and open field tests were assessed, followed by biochemical (MDA, SOD, AChE, NO, Total protein & IL-1b) assay in the PFC. Data were analyzed using one-way ANOVA (Tukey’s posthoc.). Values with p<0.05 were considered significant. Scopolamine reduced memory index (P<0.01) (cognitive function), ambulatory & rearing activities (P<0.05) (motor behavior), open arm duration (P<0.001) (anxiety-like behavior) & increased immobility time (P<0.05) (depressive-like behavior). Exposure to scopolamine also led to significant reduction in the prefrontal cortical levels of SOD (P<0.05) while increasing MDA (P<0.05), acetylcholinesterase (P<0.01) and IL-1β (P<0.05). However, levels of NO and total protein were not significantly altered. In contrast, intervention with bromelain or donepezil significantly reversed most of the behavioral and biochemical alterations induced by scopolamine. Bromelain compared favorably with donepezil in improving memory decline and other non-cognitive dysfunctions associated with scopolamine exposure. This could have resulted from modulation of oxidative stress, inflammation and cholinergic transmission.
Key words: Bromelain; Scopolamine; Oxidative stress; Neurotoxicity; Neuro-inflammation; Behavior
Референце
Adu T, Adu O & Mabandla M (2022). Effects of Bromelain on Noradrenaline Release During Anxiety-Like Behaviour Following Intra-Medial Forebrain Bundle 6-OHDA Injection in Rat Model of Parkinsonism.Surg Res, 4(2):1-7Agarwal S, Chaudhary B, Bist R (2016). Bacoside A and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum, Chem. Biol. Interact. 254: 173–178. Ajayi AM, John KA, Emmanuel IB, Chidebe EO, Adedapo DAA (2021). High-fat diet-induced memory impairment and anxiety-like behavior in rats attenuated by peel extract of Ananas comosus fruit via atheroprotective, antioxidant and anti-inflammatory actions. Metabolism Open 9:100077Ayinla M T, Asuku A O, Bayo-Olugbami A, Ayeni O A, Abiola A A and Owoyele B V (2020). Melatonin and Vitamin C modulate cholinergic neurotransmission and oxidative stress in scopolamine-induced rat model of memory impairment J. Afr. Ass. Physiol. Sci. 8 (1): 50-58Ayinla, M. T., Uthman, Y., Bayo-Olugbami, A., Oyewole, A. L. and Owoyele, B. V (2019). Effects of Ethylacetate Leaf Extracts of Ocimum gratissimum and Momordica charantia on Memory in Scopolamine-induced Dementia Rats. Nigerian Journal of Biochemistry and Molecular Biology; 34(1&2): 28-37 Bakare A.O & Owoyele B.V (2021). Bromelain reduced pro‑inflammatory mediators as a common pathway that mediate antinociceptive and anti‑anxiety effects in sciatic nerve ligated Wistar rats. Scientific Reports 11:289. doi.org/10.1038/s41598-020-79421-9Bakare, A. O. & Owoyele, B. V (2020). Antinociceptive and neuroprotective effects of bromelain in chronic constriction injury-induced neuropathic pain in Wistar rats. Korean J. Pain 33, 13–22 Bayo-Olugbami A, Nafiu AB, Amin A, Ogundele OM, Lee CC & Owoyele BV (2020). Vitamin D attenuated 6-OHDA-induced behavioural deficits, dopamine dysmetabolism, oxidative stress, and neuro-inflammation in mice, Nutritional Neuroscience, DOI:10.1080/1028415X.2020.1815331Bevins RA and Besheer J (2006). Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study recognition memory. Nat Protoc. 1: 1306–11.Bhui K, Prasad S, George J, Shukla Y (2009). Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett; 282, 167–176.Bist R, Chaudhary B, Bhatt D K (2021). Defensive proclivity of bacoside A and bromelain against oxidative stress and AChE gene expression induced by dichlorvos in the brain of Mus musculus, Sci. Rep. 11 (1): 3668.Blokland, A. (2005). Scopolamine-induced deficits in cognitive performance: A review of animal studies. Scopolamine Review. 1: 1-76.Brechin D et al. (2013). Alternatives to antipsychotic medication: psychological approaches in managing psychological and behavioural distress in people with dementia. Leicester: British Psychological Society,Byers AL & Yaffe K (2011). Depression and risk of developing dementia, Nat. Rev. Neurol. 7 (6):323–331.Chaisakdanugull C, Theerakulkait C, Wrolstad R E (2007) Pineapple juice and its fractions in enzymatic browning inhibition of banana. J. Agric. Food Chem. 55 (10): 4252–4257. Chakraborty AJ, Mitra S, Tallei TE, Tareq AM, Nainu F, Cicia D, Dhama K, Emran TB, Simal-Gandara J, Capasso R (2021). Bromelain a Potential Bioactive Compound: A Comprehensive Overview from a Pharmacological Perspective. Life 11, 317.Chaudhary B & Agarwal S, R (2018). Invulnerability of bromelain against oxidative degeneration and cholinergic deficits imposed by dichlorvos in mice brains. doi.org/10.1007/s11515-018-1479-1Donovan NJ, Amariglio RE, Zoller AS, Rudel RK, Gomez-Isla T, Blacker D, et al (2014). Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. Am J Geriatr Psychiatry. 22:1642–51. doi: 10.1016/j.jagp.2014.02.007Donovan NJ, Locascio JJ, Marshall GA, Gatchel J, Hanseeuw BJ, Rentz DM, Johnson KA, Sperling RA (2018). Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults, Am. J. Psychiatry 175 (6):530–537. Ellman, G.L., Courtney, K.D., Andres, V. and Featherstone, R.M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharm. 7(2):88-90.Eraky S M, Ramadan N M, Abo El-Magd N F (2023). Ameliorative effects of bromelain on aluminum-induced Alzheimer's disease in rats through modulation of TXNIP pathway. International Journal of Biological Macromolecules 227 (2023) 1119–1131. https://doi.org/10.1016/j.ijbiomac.2022.11.291Ferdman N, Murmu R, Bock J, et al (2007). Weaning age, social isolation, and gender, interact to determine adult explorative and social behavior, and dendritic and spine morphology in prefrontal cortex of rats. Behavioural brain research, 180: 174-182. Fernando W.M.A.D.B., Martins I.J., Goozee K.G., Brennan C.S., Jayasena V & Martins R.N. (2015) The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: Potential mechanisms of action. Br J Nutr. 114:1–14.Filarowska J, Silberring J, Kotlinska J H (2016). Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats, Naunyn Schmiedeberg's Arch. Pharmacol. 389 (10): 1059–1071.Habashi S A, Moghimi A, Sabouni F, Majd S A (2012). Inhibition of NO production in LPS-stimulated primary rat microglial cells by Bromelain. J of Cell and Mol Res, 3(2): 57–65Haider, S., Tabassum, S., Perveen, T. (2016). Scopolamine-induced greater alterations in neurochemical profile and increased oxidative stress demonstrated a better model of dementia: a comparative study. Brain Research Bulletin 127: 234–247. He, F (2011). Bradford protein assay. Bio-protocol. 20: e45-45Imran I, Javaid S, Waheed A, Rasool MF, Majeed A, Samad N, Saeed H, Alqahtani F, Ahmed MM and Alaqil FA (2021) Grewia asiatica Berry Juice Diminishes Anxiety, Depression, and Scopolamine-Induced Learning and Memory Impairment in Behavioral Experimental Animal Models. Front. Nutr. 7:587367. doi: 10.3389/fnut.2020.587367Kales HC et al. (2012). Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry; 169: 71-9.Kim E. J., Jung I. H., Jeong J. J., Kim N. J., Kim D. H. (2013). Ginsenosides Rg5 and Rh3 protect scopolamine-induced memory deficits in mice. Journal of Ethnopharmacology 146: 294-299.Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008). Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson’s disease, J. Neuroinflamm. 5:8–14.Kremer M, Becker LJ, Barrot M & Yalcin I (2020). How to study anxiety and depression in rodent models of chronic pain? Eur. J. Neurosci. 2020, 1–35.Kumar R, Kumar R, Sharma N, Khurana N, Singh SK, Satija S, Mehta M, Vyas M (2022). Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease, NeuroToxicology 90:19–34. Lee B, Shim I, Lee H, Hahm DH (2011). Rehmannia glutinosa ameliorates scopolamine-induced learning and memory impairment in rats. J Microbiol Biotechnol.21:874–83Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180e5.Livingston G et al., (2005). Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry; 162: 1996-2021.Lotrich FE (2015). Inflammatory cytokine-associated depression. Brain Res, 1617:113e25. Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2021). Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease, Neuropharmacology 190:108352. Momtazi-borojeni AA, Sadeghi-Aliabadi H, Rabbani M, Ghannadi A & Abdollahi E (2017). Cognitive enhancing of pineapple extract and juice in scopolamine-induced amnesia in mice. Research in Pharmaceutical Sciences, 12(3): 257-264Ohkawa, H., Ohishi, N., Yagi, K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry. 95(2):351-8. Oladun B T, Oyerinde A, Oyadeyi A S, Badmus H A, Onasanwo A S (2023). Effect of Cocos nucifera L. Water on Scopolamine-Induced Memory Impairment in the Wistar Rat. Nig J Neurosci 14(1): 17-25Piste P. (2013) Cysteine–Master Antioxidant. Int. J. Pharmaceut. Chem. Bio. Sci. 3, 143–149.Porsolt, R. D., Anton, G., Blavet, N., & Jalfre, M. (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology, 47(4), 379–391. doi.org/10.1016/0014-2999(78)90118-8Salim S (2014). Oxidative stress and psychological disorders. Curr Neuropharmacol. 12:140–7Sancesario GM, Nuccetelli M, Cerri A, Zegeer J, Severini C, Ciotti MT, Pieri M, Martorana A, Caltagirone C, Nistico R, Bernardini S (2018). Bromelain degrades Aβ1-42 monomers and soluble aggregates: an in vitro study in cerebrospinal fluid of Alzheimer's disease patients, Curr. Alzheimer Res. 15 (7):628–636.Sinoff G & Werner P (2003). Anxiety disorder and accompanying subjective memory loss in the elderly as a predictor of future cognitive decline, Int. J. Geriatr. Psychiatry 18 (10):951–959.Szeto JY & Lewis SJ (2016). Current treatment options for Alzheimer's disease and Parkinson's disease dementia, Curr. Neuropharmacol. 14 (4):326–338.Tochi B.N, Wang Z, Xu S.Y, Zhang W (2008). Therapeutic application of pineapple protease (Bromelain): A review. Pakistan J. Nutr. 7, 513–520.Tracey, W.R., J. Tse, and G. Carter (1995) Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther. 272(3): 1011-5. Yankelevitch-Yahav R, Franko M, Huly A, Doron R. (2015). The forced swim test as a model of depressive-like behavior. J Vis Exp. e52587.Yoshikawa T & Naito Y (2002). What Is Oxidative Stress? J of the Japan Med Association, 45(7): 271–2
##submission.downloads##
Објављено
Број часописа
Рубрика
Лиценца
Сва права задржана (c) 2025 Nigerian Journal of Physiological Sciences
Овај рад је под Creative Commons Aуторство 4.0 Интернационална лиценца.
